6 A phase III randomized trial evaluating in patients with advamced non small cell lung cancer (NSCLC) the addition of ifosfamide to a combination of cisplatin and carboplatin

✍ Scribed by Sculier, J.P.; Paesmans, M.; Thiriaux, J.; Bureau, G.; Giner, V.; Efremidis, A.; Lafitte, J.; Berchier, M.C.; Alexopoulos, C.G.; Zacharias, C.; Mommen, P.; Ninane, V.; Klastersky, J.

• Book ID: 122058233
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 152 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89285-9